Estados financieros detallados de iSpecimen Inc. (ISPC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
iSpecimen Inc. registró ingresos de $1.9M en el último ejercicio fiscal, con un CAGR de 5 años del -25.1%.
Márgenes de los últimos 12 meses: margen bruto -151.5%, margen operativo -20.2%, margen neto -24.5%.
Al precio actual de $1.37, ISPC presenta beneficios negativos (P/E no significativo) y un ROE del -5.24%. La capitalización bursátil es de $0M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $4.4M | $4.3M | $8.2M | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Coste de Ventas | $2.4M | $2.1M | $3.6M | $5.2M | $4.8M | $4.8M | $5.3M | $1.9M |
| Beneficio Bruto | $2.0M | $2.2M | $4.6M | $5.9M | $5.6M | $5.1M | $4.0M | $24110 |
| I+D | $1.2M | $993329 | $1.5M | $1.8M | $2.7M | $3.6M | $3.5M | $2.2M |
| Generales y Administrativos | $3.5M | $4.3M | $5.0M | $9.4M | $12.4M | $11.7M | $12.6M | $6.6M |
| Gastos Operativos | $5.4M | $6.1M | $7.0M | $11.8M | $15.8M | $16.3M | $16.7M | $9.0M |
| Beneficio Operativo | -$3.4M | -$3.9M | -$2.4M | -$5.9M | -$10.2M | -$11.2M | -$12.7M | -$9.0M |
| EBITDA | -$3.8M | -$2.5M | -$1.7M | -$5.9M | -$8.8M | -$8.8M | -$10.4M | -$8.7M |
| Gastos por Intereses | $1.2M | $1.7M | $2.1M | $2.1M | $238963 | $230785 | $220074 | $1949 |
| Beneficio Antes de Impuestos | -$5.5M | -$4.9M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Impuestos | -$127000 | -$157000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.3M | -$4.7M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| BPA | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| BPA Diluido | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| Acciones en Circulación (Diluidas) | $8207 | $8207 | $8207 | $10916 | $11055 | $11301 | $17771 | $115061 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $106592 | $51761 | $156009 | $151940 |
| Beneficio Bruto | -$98000 | -$547079 | $71599 | -$132816 |
| Beneficio Operativo | -$2.8M | -$2.7M | -$2.5M | -$1.4M |
| EBITDA | -$2.4M | -$4.6M | -$2.1M | -$1.2M |
| Beneficio Neto | -$2.8M | -$5.0M | -$2.3M | -$1.4M |
| BPA | $-19.05 | $-23.59 | $-6.66 | $-0.98 |
| BPA Diluido | $-19.05 | $-23.59 | $-6.66 | $-0.98 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.1M | $53893 | $695909 | $27.7M | $15.3M | $2.3M | $1.9M | $6.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $2.7M | 0 | 0 |
| Cuentas por Cobrar | $1.0M | $1.4M | $2.4M | $4.9M | $3.9M | $2.9M | $1.4M | $48298 |
| Inventario | $47287 | $54908 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $2.3M | $1.6M | $3.5M | $32.9M | $19.7M | $8.2M | $3.6M | $7.0M |
| Inmovilizado Material | $149098 | $119921 | $75589 | $32781 | $410544 | $321644 | $421540 | $294703 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $1.4M | $2.3M | $2.6M | $2.7M | $4.5M | $7.2M | $5.3M | $1.0M |
| Activos Totales | $4.0M | $4.2M | $6.2M | $35.7M | $24.6M | $15.8M | $9.4M | $9.5M |
| Cuentas por Pagar | $696912 | $737794 | $1.8M | $832678 | $2.5M | $3.9M | $4.2M | $5.4M |
| Deuda a Corto | $7.0M | $10.6M | $12.6M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $11.3M | $15.8M | $22.1M | $2.5M | $4.3M | $6.0M | $5.8M | $6.2M |
| Deuda a Largo | 0 | 0 | $178899 | $3.4M | 0 | 0 | 0 | 0 |
| Pasivos Totales | $22.5M | $26.9M | $33.5M | $5.9M | $4.3M | $6.1M | $6.0M | $6.4M |
| Reservas | -$19.7M | -$24.4M | -$29.1M | -$38.0M | -$48.3M | -$59.4M | -$71.9M | -$82.4M |
| Patrimonio Neto | -$18.4M | -$22.7M | -$27.3M | $29.8M | $20.3M | $9.7M | $3.3M | $3.1M |
| Deuda Total | $7.0M | $10.6M | $12.8M | $3.4M | $185847 | $196244 | $312167 | $268798 |
| Deuda Neta | $5.8M | $10.5M | $12.1M | -$24.3M | -$15.1M | -$4.8M | -$1.6M | -$6.6M |
| Capital Circulante | -$9.0M | -$14.2M | -$18.7M | $30.4M | $15.4M | $2.2M | -$2.2M | $723284 |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $2.8M | $6.9M | $2.8M | $4.4M |
| Activos Totales | $9.0M | $9.5M | $6.6M | $7.4M |
| Pasivos Totales | $5.9M | $6.4M | $5.8M | $5.7M |
| Patrimonio Neto | $3.1M | $3.1M | $814038 | $1.7M |
| Deuda Total | $281436 | $268798 | $254989 | $240903 |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$5.3M | -$4.7M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Amortizaciones | $469173 | $634965 | $819687 | $1.0M | $1.2M | $2.1M | $2.3M | $1.7M |
| Compensación en Acciones | $113921 | $360379 | $92866 | $622064 | $678613 | $459666 | $249675 | $21266 |
| Cambio en Capital Circulante | $368493 | $1.1M | $3.0M | -$5.3M | $2.4M | $2.6M | -$502668 | $2.1M |
| Flujo de Caja Operativo | -$2.7M | -$2.7M | -$288380 | -$10.7M | -$5.8M | -$5.8M | -$8.3M | -$4.2M |
| Inversiones (CapEx) | -$1.0M | -$1.5M | -$1.1M | -$1.0M | -$3.2M | -$4.7M | -$56547 | -$454 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | -$41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.7M | -$4.2M | -$1.4M | -$11.7M | -$9.0M | -$10.6M | -$8.3M | -$4.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$2.0M | -$916923 | -$3.4M | -$689625 |
| Inversiones (CapEx) | -$1.0M | $3 | -$4 | $5 |
| Flujo de Caja Libre | -$3.0M | -$916923 | -$3.4M | -$689620 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1797 | $1765 | $1028 | 0 |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -2.2% | +90.4% | +36.1% | -6.6% | -4.6% | -6.4% | -79.2% |
| Crecimiento Beneficio Neto (anual) | | +11.6% | +1.6% | -92.6% | -14.3% | -8.3% | -12.6% | +16.1% |
| Crecimiento BPA (anual) | | +11.6% | +1.6% | -44.8% | -12.9% | -6.0% | +28.4% | +87.0% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | +33.0% | +1.3% | +2.2% | +57.3% | +547.5% |
| Crecimiento FCF (anual) | | -12.1% | +66.5% | -741.6% | +23.0% | -17.1% | +21.4% | +48.9% |
| Margen Bruto | 46.2% | 50.5% | 56.2% | 52.9% | 54.3% | 51.4% | 42.9% | 1.2% |
| Margen Operativo | -76.4% | -90.3% | -29.4% | -53.2% | -97.9% | -112.5% | -137.0% | -465.4% |
| Margen EBITDA | -86.2% | -58.7% | -21.2% | -52.6% | -84.6% | -88.7% | -111.7% | -453.4% |
| Margen Neto | -121.7% | -110.0% | -56.8% | -80.5% | -98.5% | -111.8% | -134.5% | -543.7% |
| Margen FCF | -84.4% | -96.7% | -17.0% | -105.1% | -86.6% | -106.3% | -89.3% | -219.9% |
| Tasa Impositiva Efectiva | 2.3% | 3.2% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-451.73 | $-506.29 | $-169.49 | $-1072.40 | $-814.92 | $-933.73 | $-466.79 | $-36.86 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $8207 | $8207 | $8207 | $10916 | $11055 | $11301 | $17771 | $115061 |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -524.37% |
| Rentabilidad sobre capital invertido | -476.39% |
| Rentabilidad sobre activos | -154.47% |
| Margen bruto | -151.47% |
| Margen operativo | -2020.04% |
| Margen neto | -2449.04% |
Salud financiera
| Deuda / Patrimonio | 0.14 |
| Ratio corriente | 0.82 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -14.80 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -8.78 | -9.93 | -10.09 | -7.61 | -1.19 | -0.41 | -0.15 | -0.11 |
| P/VC | -2.55 | -2.07 | -1.72 | 2.29 | 0.60 | 0.46 | 0.57 | 0.39 |
| P/V | 10.68 | 10.92 | 5.74 | 6.12 | 1.17 | 0.46 | 0.20 | 0.62 |
| Margen Bruto | 46.2% | 50.5% | 56.2% | 52.9% | 54.3% | 51.4% | 42.9% | 1.2% |
| Margen Operativo | -76.4% | -90.3% | -29.4% | -53.2% | -97.9% | -112.5% | -137.0% | -465.4% |
| Margen Neto | -121.7% | -110.0% | -56.8% | -80.5% | -98.5% | -111.8% | -134.5% | -543.7% |